Status:
UNKNOWN
Neurotoxicity of Spinal Anesthesia With Ropivacaine and Bupivacaine
Lead Sponsor:
University of Rzeszow
Collaborating Sponsors:
Department of Anesthesiology, Intensive Therapy, District Hospital No2 in Rzeszow
Conditions:
Anesthesia; Adverse Effect, Spinal and Epidural
Anaesthetic Complication Neurological
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Consenting patients, scheduled for orthopaedic surgery under spinal anesthesia will be randomly assigned (1:1) to receive ropivacaine or bupivacaine as a single shot before the start of surgery, follo...
Detailed Description
With the approval from the Bioethical Committee of the University of Rzeszow, informed written consent will be obtained from all patients. A sample size of 60 patients was calculated to obtain at lea...
Eligibility Criteria
Inclusion
- \- Orthopedic procedures in the lower limbs Written informed consent
Exclusion
- Patients' refusal Known allergies to study medications Inability to comprehend or participate in pain scoring scale Anatomic, posttraumatic and postoperative deformations of the spinal column making placement of intrathecal catheter impossible Neurological contraindications Any other contraindications for spinal anesthesia (coagulations disorders, antiplatelet or anticoagulant treatment, infection at the puncture site.
Key Trial Info
Start Date :
December 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2019
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03293472
Start Date
December 1 2017
End Date
December 31 2019
Last Update
December 18 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Rzeszow
Rzeszów, Poland, 35310